-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Stifel Downgrades Fate Therapeutics to Hold From Buy, Adjusts Price Target to $5.30 From $107

Stifel Downgrades Fate Therapeutics to Hold From Buy, Adjusts Price Target to $5.30 From $107

MT Newswires · 01/06/2023 05:17